SEARCH

SEARCH BY CITATION

REFERENCES

  • Anderson GD. (2002) Children versus adults: pharmacokinetic and adverse-effect differences. Epilepsia 43(suppl 3):5359.
  • Brodie MJ, Richens A, Yuen AW. (1995) Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345:476479.
  • Brodie MJ, Overstall PW, Giorgi L. (1999) Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Research 37:8187.
  • Chadwick D. (1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 354:1319.
  • Cloyd J. (1991) Pharmacokinetic pitfalls of present antiepileptic medications. Epilepsia 32(suppl 5):S53S65.
  • Da Silva JA. (1999) Sex hormones and glucocorticoids: interactions with the immune system. Annals of the New York Academy of Sciences 876:102117.
  • Friis ML, Kristensen O, Boas J, Dalby M, Deth SH, Gram L, Mikkelsen M, Pedersen B, Sabers A, Worm-Petersen J. (1993) Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurologica Scandinavica 87:224227.
  • Galindo PA, Borja J, Gomez E, Mur P, Gudin M, Garcia R, Encinas C, Romero G, Garrido JA, Cortina P, Feo F. (2002) Anticonvulsant drug hypersensitivity. Journal of Investigational Allergology and Clinical Immunology 12:299304.
  • Greenwood RS. (2000) Adverse effects of antiepileptic drugs. Epilepsia 41(suppl 2):S42S52.
  • Grossman CJ. (1984) Regulation of the immune system by sex steroids. Endocrine Reviews 5:435455.
  • Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, Richens A, Stern RS, Trevathan E. (1999) Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 40:985991.
  • Hirji KF (2006) Exact analysis of discrete data. Chapman & Hall/CRC, Boca Raton , pp. 218219.
  • Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M, Resor SR Jr. (2006) Predictors of lamotrigine-associated rash. Epilepsia 47:318322.
  • Hung S-I, Chung W-H, Jee S-H, Chen W-C, Chang Y-T, Lee W-R, Hu S-L, Wu M-T, Chen G-S, Wong T-W, Hsiao P-F, Chen W-H, Shih H-Y, Fang W-H, Wei C-Y, Lou Y-H, Huang Y-L, Lin J-J, Chen Y-T. (2006) Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenetics and Genomics 16:297306.
  • Hyson C, Sadler M. (1997) Cross sensitivity of skin rashes with antiepileptic drugs. Canadian Journal of Neurological Sciences 24:245249.
  • Kalis MM, Huff NA. (2001) Oxcarbazepine, an antiepileptic agent. Clinical Therapeutics 23:680700.
  • Knowles SR, Shapiro LE, Shear NH. (1999) Anticonvulsant hypersensitive syndrome. Incidence, prevention and management. Drug Safety 6:489501.
  • Leeder JS. (1998) Mechanisms of idiosyncratic hypersensitivity to antiepileptic drugs. Epilepsia 38(suppl 7):S8S16.
  • Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD. (1997) Safety of long-term lamotrigine in epilepsy. Epilepsia 38:881886.
  • Maggs JL, Naisbitt DJ, Tettey JNA, Pirmohamed M, Park BK. (2000) Metabolism of lamotrigine to a reactive arene oxide intermediate. Chemical Research in Toxicology 13:10751081.
  • Matsuo F. (1999) Lamotrigine. Epilepsia 40(suppl 5):S30S36.
  • Mattson RH, Cramer JA, Collins JF, Smith DB, Gado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB. (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine 313:145151.
  • Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. (2005) Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64:11341138.
  • Osman M. (2003) Therapeutic implications of sex differences in asthma and atopy. Archives of Disease in Childhood 88:587590.
  • Park LC, Albers DS, Xu H, Lindsay JG, Beal MF, Gibson GE. (2001) Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. Journal of Neuroscience Research 66:10281034.
  • Rapp RP, Norton JA, Young B, Tibbs PA. (1983) Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery 13:272275.
  • Roujeau J-C. (2006) Immune mechanisms in drug allergy. Allergology International 55:2733.
  • Schmidt D, Sachdeo R. (2000) Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy & Behavior 1:396405.
  • Shamssain MH, Shamsian N. (1999) Prevalence and severity of asthma, rhinitis, and atopic eczema: the north east study. Archives of Disease in Childhood 81:313317.
  • Strachan DP. (1989) Hay fever, hygiene, and household size. BMJ: British Medical Association 299:12591260.
  • Sullivan JR, Shear NH. (2002) Drug eruptions and other adverse drug effects in aged skin. Clinics in Geriatric Medicine 18:2142.
  • Talal N. (1987) Autoimmune mechanisms in patients and animal models. Toxicologic Pathology 15:272275.
  • Tran C, Knowles SR, Liu BA, Shear NH. (1998) Gender differences in adverse drug reactions. Journal of Clinical Pharmacology 38:10031009.
  • Vercelli D. (2006) Mechanisms of the hygiene hypothesis—molecular and otherwise. Current Opinion in Immunology 18:733737.
  • Wong IC, Mawer GE, Sander JW. (1999) Factors influencing the incidence of lamotrigine-related skin rash. The Annals of Pharmacotherapy 33:10371042.